Mint Explainer | Why are generic weight loss drugs losing steam?
What are semaglutide generics?
Semaglutide is the compound name for Novo Nordisk’s weight-loss and type-2 diabetes drug, better known by the brand names Wegovy and Ozempic. The drug lost its patent exclusivity in India in late March, triggering a host of generic, or copycat, versions of the drug, launched at cheaper (50-90% lower) costs. Over 30 brands were launched soon after patent expiry by several companies, including Dr Reddy’s Laboratories, Sun Pharma, Torrent Pharma, Glenmark, Eris Lifesciences, Zydus Lifesciences and more. The launches triggered a price war as well, with the innovator soon slashing their own prices.
Post Comment